AWS Launches Amazon Bio Discovery to Speed AI Drug Development | PYMNTS.com

Amazon Bio Discovery, announced last week, is designed to offer scientists direct access to a wide range of specialized AI models known on biological foundation models (bioFMs) that are trained using large biological datasets. 

“These models generate and evaluate potential drug molecules, known as candidates, helping scientists accelerate antibody therapies during the early stages of drug discovery,” the announcement said. “But access alone is not enough.”

Amazon Bio Discovery allows scientists to converse naturally in their preferred terminology with an AI agent to choose the appropriate models for their research goals, optimize inputs and gauge candidates for experimentation, the announcement said.

In addition, scientists also train models on their prior experimental data for more accurate predictions, and send candidates to physical labs for synthesis…